OCA at 14:13, 18 October 2023

2023-10-18T14:13:37Z

←Older revision		Revision as of 14:13, 18 October 2023
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8uf5 is ~~ON HOLD~~	+	==Catalytic domain of GtfB in complex with inhibitor G43==
		+	<StructureSection load='8uf5' size='340' side='right'caption='[[8uf5]], [[Resolution\|resolution]] 2.50Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8uf5]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_mutans Streptococcus mutans]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8UF5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8UF5 FirstGlance]. <br>
		+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.5Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BTB:2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>BTB</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=WIJ:N-(2-carbamoylphenyl)-5-nitro-1-benzothiophene-2-carboxamide'>WIJ</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8uf5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8uf5 OCA], [https://pdbe.org/8uf5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8uf5 RCSB], [https://www.ebi.ac.uk/pdbsum/8uf5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8uf5 ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/GTFB_STRMU GTFB_STRMU] Production of extracellular glucans, that are thought to play a key role in the development of the dental plaque because of their ability to adhere to smooth surfaces and mediate the aggregation of bacterial cells and food debris.
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Streptococcus mutans employs a key virulence factor, three glucosyltransferase (GtfBCD) enzymes to establish cariogenic biofilms. Therefore, the inhibition of GtfBCD would provide anti-virulence therapeutics. Here a small molecule library of 500,000 small molecule compounds was screened in silico against the available crystal structure of the GtfC catalytic domain. Based on the predicted binding affinities and drug-like properties, small molecules were selected and evaluated for their ability to reduce S. mutans biofilms, as well as inhibit the activity of Gtfs. The most potent inhibitor was further characterized for Gtf binding using OctetRed instrument, which yielded low micromolar KD against GtfB and nanomolar KD against GtfC, demonstrating selectivity towards GtfC. Additionally, the lead compound did not affect the overall growth of S. mutans and commensal oral bacteria, and selectively inhibit the biofilm formation by S. mutans, indicative of its selectivity and non-bactericidal nature. The lead compound also effectively reduced cariogenicity in vivo in a rat model of dental caries. An analog that docked poorly in the GtfC catalytic domain failed to inhibit the activity of Gtfs and S. mutans biofilms, signifying the specificity of the lead compound. This report illustrates the validity and potential of structure-based design of anti-S. mutans virulence inhibitors.

-	~~Authors: Schormann, N~~., ~~Deivanayagam~~, C., Velu, S.	+	Structure-Based Discovery of Small Molecule Inhibitors of Cariogenic Virulence.,Zhang Q, Nijampatnam B, Hua Z, Nguyen T, Zou J, Cai X, Michalek SM, Velu SE, Wu H Sci Rep. 2017 Jul 20;7(1):5974. doi: 10.1038/s41598-017-06168-1. PMID:28729722<ref>PMID:28729722</ref>

-	~~Description: Catalytic domain~~ of ~~GtfB in complex with inhibitor G43~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
-	[[Category: ~~Schormann, N~~]]	+	<div class="pdbe-citations 8uf5" style="background-color:#fffaf0;"></div>
-	[[Category: ~~Velu, S~~]]	+	== References ==
-	[[Category: ~~Deivanayagam, C~~]]	+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Streptococcus mutans]]
		+	[[Category: Deivanayagam C]]
		+	[[Category: Schormann N]]
		+	[[Category: Velu S]]

OCA: Protected "8uf5" [edit=sysop:move=sysop]

2023-10-11T04:50:37Z

Protected "8uf5" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:50, 11 October 2023

OCA: New page: '''Unreleased structure''' The entry 8uf5 is ON HOLD Authors: Schormann, N., Deivanayagam, C., Velu, S. Description: Catalytic domain of GtfB in complex with inhibitor G43 [[Category: ...

2023-10-11T04:50:36Z

New page: '''Unreleased structure''' The entry 8uf5 is ON HOLD Authors: Schormann, N., Deivanayagam, C., Velu, S. Description: Catalytic domain of GtfB in complex with inhibitor G43 [[Category: ...

New page

'''Unreleased structure'''

The entry 8uf5 is ON HOLD

Authors: Schormann, N., Deivanayagam, C., Velu, S.

Description: Catalytic domain of GtfB in complex with inhibitor G43
[[Category: Unreleased Structures]]
[[Category: Schormann, N]]
[[Category: Velu, S]]
[[Category: Deivanayagam, C]]

8uf5 - Revision history

OCA at 14:13, 18 October 2023

OCA: Protected "8uf5" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8uf5 is ON HOLD Authors: Schormann, N., Deivanayagam, C., Velu, S. Description: Catalytic domain of GtfB in complex with inhibitor G43 [[Category: ...